Define the role of REV-ERB in colonic RORgt+ regulatory T cells
定义 REV-ERB 在结肠 RORgt 调节性 T 细胞中的作用
基本信息
- 批准号:10753360
- 负责人:
- 金额:$ 28.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-11 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgonistAntibodiesAutoimmune DiseasesAutoimmunityBindingBiological AssayCTLA4 geneCell LineageCell physiologyCellsColitisColonColonic inflammationDataDevelopmentEquilibriumFOXP3 geneFamilyGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGoalsHomeostasisHumanImmune systemImmunosuppressive AgentsInflammationInflammatoryInflammatory Bowel DiseasesInsulin-Dependent Diabetes MellitusInterleukin-10Knock-outKnockout MiceLamina PropriaLeadLinkLymphoproliferative DisordersMaintenanceMapsMediatingMolecularMultiple SclerosisMusNuclear Hormone ReceptorsNuclear ReceptorsOrphanOutcomeOutcome StudyPlayPopulationPredispositionReceptor InhibitionRegulatory T-LymphocyteRepressionResearchRoleRunningSideSpleenT-LymphocyteTestingTissuesTranscription CoactivatorTranscription Factor 3Transcription RepressorTretinoinWorkanti-tumor immune responseconditional knockoutexperimental studygenome-wideimmunopathologyin vivoin vivo Modelinsightloss of function mutationmembermouse modelmurine colitisnew therapeutic targetnext generation sequencingpreventprotective effectreceptorreceptor functiontherapeutic developmenttherapeutic targettranscription factortranscriptome sequencing
项目摘要
PROJECT SUMMARY
Regulatory T cells (Treg) play a crucial role in keeping the immune system in balance and preventing
autoimmune disease. Defective Treg function leads to autoimmune diseases, while intra-tumor Tregs can block
effective anti-tumor immune responses. Tregs can undergo further specialization in adaptation to their tissue
microenvironment. Recent studies showed that a unique RORgt (retinoic acid–related orphan receptor gamma
t) expressing Treg cell population could be induced in the colon lamina propria. These RORgt+ Tregs play an
important role in the suppression of colon inflammation. In Treg cells, REV-ERBa is highly expressed in RORgt+
colonic Tregs, but not in RORgt- colonic Tregs or spleen Tregs. Mice with Treg-specific deletion of REV-ERB
were more susceptible to TNBS-induced colitis with decreased RORgt+ Treg cells and increased Th1/Th17 cell-
mediated inflammation in the colon. RNA-sequencing experiment showed that the expression of a set of genes
related to Treg function, including CTLA-4, IL-10, and c-Maf, were reduced in REV-ERB deficient colonic Tregs
compared to WT controls. To study the mechanism of gene regulation by REV-ERB in Tregs, Dr. Zheng’s lab
performed Cut & Run assays with WT RORgt+ iTregs using Foxp3, REV-ERBa, and RORgt antibodies to map
their binding peaks genome-wide. The results showed a significant overlap of the binding peaks of these 3
transcription factors, suggesting coordination in gene regulation among Foxp3, REV-ERB, and RORgt in Treg
cells. The overall objective of the proposed study is to define the role of REV-ERB in Treg function. This goal will
be accomplished by dissecting the molecular mechanism of REV-ERB function in RORgt+ Treg cells (Aim 1),
and characterizing the role of REV-ERB in Treg in mouse models of IBD (Aim 2). The outcomes of the proposed
study are expected to reveal the functional and mechanistic role of REV-ERB in RORgt+ Tregs. Such results are
expected to further advance our understanding of how the identity and function of RORgt+ Tregs are established
and maintained. Additionally, this study will provide key insights into how transcriptional repressor such as REV-
ERB serves as key regulator and tune the function of transcriptional activators in Treg cells. Finally, the outcomes
of this study could provide evidence supporting the development of therapeutics targeting REV-ERB for IBD
treatment.
项目摘要
调节性T细胞(Treg)在保持免疫系统平衡和预防免疫系统疾病方面起着至关重要的作用。
自身免疫性疾病Treg功能缺陷导致自身免疫性疾病,而肿瘤内的Treg可以阻断
有效的抗肿瘤免疫应答。在适应组织的过程中,
微环境。最近的研究表明,一个独特的RORgt(维甲酸相关孤儿受体γ),
t)可以在结肠固有层中诱导表达Treg细胞群。这些RORgt+ THEORY扮演一个
在抑制结肠炎症中的重要作用。在Treg细胞中,REV-ERBa在RORgt+中高度表达。
结肠T淋巴细胞,但不存在于RORgt-结肠T淋巴细胞或脾T淋巴细胞中。Treg特异性REV-ERB缺失的小鼠
对TNBS诱导的结肠炎更敏感,RORgt+ Treg细胞减少,Th 1/Th 17细胞增加。
介导的结肠炎症。RNA测序实验表明,一组基因的表达
在REV-ERB缺陷的结肠T细胞中,与Treg功能相关的细胞因子,包括CTLA-4、IL-10和c-Maf,
与WT对照相比。为了研究REV-ERB在Tumor中的基因调控机制,郑博士实验室
使用Foxp 3、REV-ERBa和RORgt抗体,用WT RORgt+ iTclad进行Cut & Run测定,以定位
它们的结合峰值在全基因组范围内。结果表明,这3种化合物的结合峰有明显重叠
转录因子,表明Treg中Foxp 3,REV-ERB和RORgt之间的基因调控协调
细胞拟议研究的总体目标是确定REV-ERB在Treg功能中的作用。这一目标将
通过剖析RORgt+ Treg细胞中REV-ERB功能的分子机制来实现(目的1),
以及表征IBD小鼠模型中REV-ERB在Treg中的作用(目的2)。拟议会议的成果
这些研究有望揭示REV-ERB在RORgt+ THBE中的功能和机制作用。这样的结果
预计将进一步加深我们对RORgt+ Treg的身份和功能如何确定的理解
并保持。此外,这项研究将提供关键的见解,如何转录阻遏物,如REV-
ERB是调节Treg细胞转录激活因子功能的关键因子。最后,结果
这项研究的结果可以为开发针对IBD的REV-ERB治疗药物提供证据
治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ye Zheng其他文献
Ye Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ye Zheng', 18)}}的其他基金
A novel role of hypusination in controlling regulatory T cell function
hypusination 在控制调节性 T 细胞功能中的新作用
- 批准号:
10356173 - 财政年份:2021
- 资助金额:
$ 28.5万 - 项目类别:
Investigating the interplay of structural, molecular and spatial mechanisms that control SHP2 activity downstream of PD1
研究控制 PD1 下游 SHP2 活性的结构、分子和空间机制的相互作用
- 批准号:
10002277 - 财政年份:2018
- 资助金额:
$ 28.5万 - 项目类别:
Treg development and function controlled by cis-regulatory circuits
由顺式调节电路控制的 Treg 发育和功能
- 批准号:
10318638 - 财政年份:2014
- 资助金额:
$ 28.5万 - 项目类别:
Regulatory T cell lineage stability controlled by Foxp3 CNS2
Foxp3 CNS2 控制的调节性 T 细胞谱系稳定性
- 批准号:
9197261 - 财政年份:2014
- 资助金额:
$ 28.5万 - 项目类别:
Treg development and function controlled by cis-regulatory circuits
由顺式调节电路控制的 Treg 发育和功能
- 批准号:
10092894 - 财政年份:2014
- 资助金额:
$ 28.5万 - 项目类别:
Mechanisms controlling Foxp3 expression and regulatory T cell homeostasis
控制 Foxp3 表达和调节性 T 细胞稳态的机制
- 批准号:
8658598 - 财政年份:2013
- 资助金额:
$ 28.5万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 28.5万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 28.5万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 28.5万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 28.5万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别: